Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter
From Critical Care Explorations
The authors sought to determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support.
Authors:
Olson SW, Oliver JD, Collen J, et al.
Estimated Time: 12:23
Categories:
Crisis Management, Pulmonary,
Content Type:
Articles,